SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-15-000049
Filing Date
2015-07-20
Accepted
2015-07-17 18:05:49
Documents
4
Period of Report
2015-07-20
Effectiveness Date
2015-07-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2015.htm DEF 14A 570267
2 LJPC LOGO image1.jpg GRAPHIC 164429
3 proxycard2015001.jpg GRAPHIC 183239
4 proxycard2015002.jpg GRAPHIC 105619
  Complete submission text file 0000920465-15-000049.txt   1196256
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 15994708
SIC: 2836 Biological Products, (No Diagnostic Substances)